Cargando…

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve

BACKGROUND: Current guidelines recommend the utilization of direct-acting oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (AF). However, the optimal anticoagulation strategy for AF patients with bioprosthetic heart valves (BPHV) remains controversial. Therefore, we cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yalin, Zheng, Yuxiang, Li, Siyuan, Liu, Fuwei, Xue, Zhengbiao, Yin, Kang, Luo, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248967/ https://www.ncbi.nlm.nih.gov/pubmed/35783817 http://dx.doi.org/10.3389/fcvm.2022.899906

Ejemplares similares

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Liu, Fuwei, et al.
Publicado: (2021)

Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta‐analysis
por: Yan, Jie, et al.
Publicado: (2022)

Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose–Response Meta-Analysis of Prospective Studies
por: Cao, Yalin, et al.
Publicado: (2022)

Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis
por: Zeng, Shan, et al.
Publicado: (2022)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
por: Wang, Lu, et al.
Publicado: (2023)

DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions
por: Ryu, Rachel, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials
por: Liu, Fuwei, et al.
Publicado: (2022)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2021)

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
por: Noviyani, Rini, et al.
Publicado: (2022)

Bioprosthetic valve monitoring in patients with carcinoid heart disease
por: Honan, Kevin A., et al.
Publicado: (2023)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Impact of COPD or Asthma on the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Xue, Zhengbiao, et al.
Publicado: (2022)

Left Atrial Thrombus in a Patient with Mitral Bioprosthetic Valve
por: Tas, Muhammed Hakan, et al.
Publicado: (2013)

Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves
por: Williams, David F., et al.
Publicado: (2021)

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years
por: Yu, Jun, et al.
Publicado: (2022)

Transcatheter Mitral Valve-in-Valve Implantation With a New Transcatheter Heart Valve for Bioprosthetic Degeneration
por: Lu, Yuntao, et al.
Publicado: (2022)

Degeneration of Bioprosthetic Heart Valves: Update 2020
por: Kostyunin, Alexander E., et al.
Publicado: (2020)

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
por: van Gorp, Rick H., et al.
Publicado: (2015)

DOACs or VKAs or LMWH – What is the optimal regimen for cancer-associated venous thromboembolism? A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2022)

Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology
por: Li, Kan Yan Chloe
Publicado: (2019)

Intravenous thrombolysis for bioprosthetic valve thrombosis
por: Adrichem, Rik, et al.
Publicado: (2023)

Performance of xenogeneic pulmonary visceral pleura as bioprosthetic heart valve cusps in swine
por: Lu, Xiao, et al.
Publicado: (2023)

Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost
por: Human, Paul, et al.
Publicado: (2022)

Surgical Ablation of Atrial Fibrillation in Patients Undergoing Bioprosthetic Valve Replacement
por: Pyo, WonKyung, et al.
Publicado: (2019)

Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021)

Efficacy and Safety of NOACs Compared With VKAs for Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A System Review and Meta-Analysis
por: Ge, Junye, et al.
Publicado: (2022)

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2022)

Fibrin deposition on bovine pericardium tissue used for bioprosthetic heart valve drives its calcification
por: Poitier, Bastien, et al.
Publicado: (2023)

Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis
por: Petrou, Emmanouil, et al.
Publicado: (2014)

Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018)

The future of bioprosthetic heart valves
por: Manji, Rizwan A., et al.
Publicado: (2012)

Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2021)

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
por: Guimarães, Patricia O., et al.
Publicado: (2019)

Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve
por: Kang, Do-Yoon, et al.
Publicado: (2018)

Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses
por: Lange, Rüdiger, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2022)

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
por: Spinoni, Enrico Guido, et al.
Publicado: (2022)

Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials
por: Lin, Chun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4rohjo142c1l85tb95omiq47o